It revealed awards in 4 categories - first place for Best Indica Concentrates and pole position in Best Sativa Concentrates
() (OTCMKTS:AUSAF) revealed that its brands Tsunami and GT Flowers have received accolades at the High Times Cannabis Cup Nevada 2019 - the premier competition in the US cannabis industry.
The company revealed awards in four categories - first-place position for Best Indica Concentrates and also pole position in Best Sativa Concentrates.
READ: Australis Capital strengthens leadership team with Alex Han as chief accounting officer
It won second place in Best Hybrid Concentrates and third placing in the Vape Cartridges section.
"The great showing at the High Times Cup validates the hard work, creativity and care Green Therapeutics uses when approaching the cultivation and extraction processes," said Dr. Duke Fu, chief executive of Green Therapeutics.
"We are proud to have been successful in the manufacturing and creation of differentiated products that bring joy to our customers."
Cleve Tzung, from Australis, added: "These wins along with the growth of AUSA's brands in Nevada prove that marijuana brands built on quality cultivation, extraction, marketing, and management will thrive and grow with the consumer.
"We're very proud of the GT team that was acquired less than a year ago and look forward to introducing our award-winning brands to new markets in the coming months."
Expanding industry
As the cannabis industry continues to expand, consumers are seeking premium-quality cannabis options from quality suppliers, said Australis.
"Tsunami, Provisions, and GT Flowers answer this demand with high-quality, innovative products, a wide array of phenotypes, and broad distribution through some of the largest dispensaries in Nevada, including Planet 13, The Source, and THRIVE Marketplace," it added.
The focus for the three is to continue to increase sales, focusing on high turnover SKUs to supply the high volume demands from some of the largest dispensaries in Nevada, while expanding and developing new dispensary partnerships.
Shares in Canada were unchanged at C$0.45.
Contact the author at [email protected]
